Wise Mind Herbs

The information on this page has been prepared with reference to published scientific literature, not by a medically qualified expert. It is not medical advice. Any decision to use a supplement or herb-based product is your responsibility. Consult a suitably qualified medical professional, especially if you have underlying conditions. Remember, nothing is for everyone, and not everything sold is what it claims to be. Some things work for some people, some of the time.

Plantain - Plantago lanceolata

Plantago is a genus of about 200 species of small, inconspicuous plants commonly known as plantains. The two most medically significant species are Plantago lanceolata (ribwort plantain, narrow-leaf plantain, English plantain) and Plantago major (broadleaf plantain, greater plantain, common plantain). These plants have a long history in traditional medicine across various cultures and have gained attention in modern scientific research for their potential therapeutic properties.

Image source and license: https://commons.wikimedia.org/wiki/File:Plantago_lanceolata_-_2011-05-06_-_248b.jpg.
Modified by Peter Jorgensen.

Botanical Classification and Common Names

Plantago lanceolata and Plantago major belong to the Plantaginaceae family. Despite sharing the common name "plantain," these medicinal herbs should not be confused with the cooking banana (Musa paradisiaca) also called plantain in many regions. Other species in the genus include Plantago ovata (psyllium or ispaghula), Plantago asiatica (Chinese plantain), and Plantago media (hoary plantain), which have different properties and uses.

Bioactive Compounds

The therapeutic potential of Plantago species is attributed to several bioactive compounds including: aucubin and catalpol (iridoid glycosides), plantamajoside, acteoside, mucilage, flavonoids (including luteolin), tannins, phenolic acids, and polysaccharides. The concentration of these compounds varies depending on the species, part of the plant used, growth conditions, and harvest time.

Evidence-Based Health Benefits

Scientific research supports several medicinal applications of Plantago species, though the quality of evidence varies considerably across conditions:

• Respiratory conditions: Multiple clinical studies support the efficacy of Plantago extracts for respiratory conditions. The mucilage and iridoid glycosides in Plantago species demonstrate antitussive, expectorant, and anti-inflammatory effects beneficial for bronchitis, cough, and upper respiratory tract infections.
• Wound healing: Both in vitro and in vivo studies confirm the wound healing properties of Plantago major and P. lanceolata. The allantoin content promotes cell proliferation while the aucubin exhibits antimicrobial activity beneficial for wound healing.
• Anti-inflammatory effects: Several studies demonstrate significant anti-inflammatory activity, with plantamajoside and acteoside compounds inhibiting pro-inflammatory mediators.
• Gastrointestinal disorders: Research supports the use of Plantago for irritable bowel syndrome, inflammatory bowel disease, and peptic ulcers, with mucilage content providing protective effects on gastric mucosa.
• Antimicrobial activity: In vitro studies show effectiveness against several bacterial strains including Staphylococcus aureus and Pseudomonas aeruginosa, though clinical validation is limited.
• Immunomodulatory effects: Polysaccharides from Plantago demonstrate immune-enhancing properties in experimental models.
• Antioxidant properties: Various extracts show free radical scavenging activity, potentially protecting against oxidative stress-related diseases.

Conditions with Supporting Evidence

• Bronchitis and cough (moderate evidence)
• Minor wounds, burns, and skin inflammation (moderate evidence)
• Inflammatory conditions (moderate evidence)
• Peptic ulcers (limited evidence)
• Irritable bowel syndrome (limited evidence)
• Oral mucositis (limited evidence)
• Conjunctivitis (limited evidence)
• Antioxidant support (moderate evidence, based on in vitro studies)

Recommended Dosages

Clinical studies typically use the following dosages, though standardization varies considerably:

• Dried leaf: 1-3g of dried leaf material taken three times daily
• Liquid extract (1:1 in 25% ethanol): 1-2mL three times daily
• Tincture (1:5 in 45% ethanol): 2-4mL three times daily
• For standardized extracts (containing 2-3% aucubin): 250-500mg twice daily
• Topical applications: Fresh leaves crushed and applied directly to wounds, or commercial preparations containing 10-20% Plantago extract

Most studies have not established clear dose-response relationships, and optimal therapeutic doses for specific conditions remain undetermined. The European Medicines Agency has approved traditional use at these dosages but notes that formal dose-optimization studies are lacking.

Research on Higher Dosages

Limited research exists on doses significantly above those mentioned. A few toxicological studies in animals have tested higher concentrations without reporting acute toxicity, but systematic evaluations of high-dose efficacy or safety in humans represent a significant knowledge gap. No clinical trials have explicitly focused on dose-ranging studies to establish maximum effective doses. This represents an important area for future research.

Side Effects and Safety Concerns

Plantago species are generally considered safe when used appropriately, but several adverse effects have been documented:

• Allergic reactions: Contact dermatitis and allergic rhinitis have been reported, particularly in individuals with pre-existing pollen allergies
• Gastrointestinal disturbances: High doses may cause mild nausea, bloating, or diarrhea
• Potential anticoagulant effects: Some studies suggest possible interactions with anticoagulant medications due to vitamin K content
• Hypotension: Large amounts may potentially lower blood pressure
• Pregnancy concerns: Insufficient safety data for pregnant or breastfeeding women

Drug Interactions

Caution is advised when using Plantago preparations alongside:

• Anticoagulant medications (possible enhanced effect)
• Antidiabetic drugs (potential hypoglycemic effects)
• Diuretics (possible additive effect)
• Lithium (altered absorption)
• Oral medications generally (may affect absorption if taken simultaneously)

Limitations of Current Research

Despite promising results, research on Plantago species faces several limitations:

• Inconsistent standardization of extracts across studies
• Small sample sizes in many clinical trials
• Variation in methodological quality
• Limited pharmacokinetic data on active compounds
• Insufficient investigation of long-term safety
• Lack of direct comparative studies with conventional medications

Conclusion

Plantago species, particularly P. lanceolata and P. major, show promise for various therapeutic applications based on traditional use and emerging scientific evidence. The strongest evidence supports their use for respiratory conditions, wound healing, and inflammatory disorders. However, more rigorous clinical trials with standardized preparations are needed to establish optimal dosing regimens and confirm efficacy for specific indications. As with many herbal remedies, quality control and standardization remain significant challenges in both research and commercial applications.

References

Abate, L., Bachheti, R. K., Tadesse, M. G., & Bachheti, A. (2022). Ethnobotanical uses, chemical constituents, and application of Plantago lanceolata L. Journal of Chemistry, 2022(1), 1532031.

Adom, M. B., Taher, M., Mutalabisin, M. F., Amri, M. S., Kudos, M. B. A., Sulaiman, M. W. A. W., ... & Susanti, D. (2017). Chemical constituents and medical benefits of Plantago major. Biomedicine & pharmacotherapy, 96, 348-360.

Gomez‐Flores, R., Calderon, C. L., Scheibel, L. W., Tamez‐Guerra, P., Rodriguez‐Padilla, C., Tamez‐Guerra, R., & Weber, R. J. (2000). Immunoenhancing properties of Plantago major leaf extract. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 14(8), 617-622.

Lukova, P., Dimitrova-Dyulgerova, I., Karcheva-Bahchevanska, D., Mladenov, R., Iliev, I., & Nikolova, M. (2017). Comparative morphological and qualitative phytochemical analysis of Plantago media L. leaves with P. major L. and P. lanceolata L. leaves. International Journal of medical research and pharmaceutical sciences, 4(6), 20-26.

Melese, E., Asres, K., Asad, M., & Engidawork, E. (2011). Evaluation of the antipeptic ulcer activity of the leaf extract of Plantago lanceolata L. in rodents. Phytotherapy research, 25(8), 1174-1180.

Pol, M., Schmidtke, K., & Lewandowska, S. (2021). Plantago lanceolata–An overview of its agronomically and healing valuable features. Open agriculture, 6(1), 479-488.

Rahamouz-Haghighi, S., Kh, B., Mohsen-Pour, N., & Sharafi, A. (2022). In vitro evaluation of cytotoxicity and antibacterial activities of ribwort plantain (plantago lanceolata L.) root fractions and phytochemical analysis by gas chromatography-mass spectrometry. Archives of Razi Institute, 77(6), 2131.